
The FTA Cautionary Tale: What India-Korea Trade Warns Us About New Global Deals
Why It Matters
The widening deficit signals that India’s current FTA framework may favor partners, risking domestic industry competitiveness. Adjusting CEPA could set a template for fairer future trade agreements.
Key Takeaways
- •India‑Korea trade rose from $12B to $27.4B (2009‑2024)
- •Indian imports from Korea grew 5.8% annually, outpacing exports
- •India's trade deficit with Korea more than tripled since 2010
- •Goyal calls CEPA “not working for India” and seeks renegotiation
Pulse Analysis
India’s push to reassess its 2010 CEPA with South Korea arrives at a pivotal moment for its broader trade strategy. While the partnership has lifted total bilateral commerce to $27.4 billion, the skewed growth—5.8% annual import expansion versus a modest 2.6% export rise—has left India with a three‑fold larger deficit. Analysts argue that the agreement’s rules of origin and tariff concessions favor Korean high‑tech and automotive sectors, limiting Indian firms’ ability to compete on price and scale.
The imbalance underscores a systemic challenge for India as it accelerates its FTA agenda, most recently sealing a deal with the European Union. Policymakers must reconcile the desire for market access with safeguards that protect nascent domestic industries. Potential levers include renegotiating tariff schedules, tightening rules of origin, and embedding capacity‑building clauses that encourage technology transfer and joint ventures.
Looking ahead, the CEPA review could become a benchmark for future agreements, signaling to partners that India seeks reciprocity rather than one‑sided gains. A rebalanced pact would not only curb the trade deficit but also stimulate export diversification into sectors like pharmaceuticals, renewable energy, and digital services. By aligning trade terms with strategic economic objectives, India can leverage FTAs as engines of growth rather than sources of imbalance.
The FTA cautionary tale: What India-Korea trade warns us about new global deals
Comments
Want to join the conversation?
Loading comments...